Navigation Links
Sanovas Fills Corporate Bench with Industry Veterans In Clinical, Regulatory and Finance
Date:9/11/2012

SAUSALITO, Calif., Sept. 11, 2012 /PRNewswire/ -- Sanovas Inc., a life science  technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has hired three  industry veterans to serve on its executive team. Mike Humason joins Sanovas as vice president of clinical affairs and physician education; Carlos Gonzalez joins as vice president of regulatory affairs and quality assurance, and Robert E. Farrell joins as chief financial officer.

"As Sanovas accelerates toward commercialization, we are committed to building an executive team comprised of talented and seasoned leaders, particularly in the critical areas of clinical affairs, regulatory affairs and finance," Sanovas CEO Larry Gerrans said. "Mike, Carlos and Bob bring over 100 years of professional expertise and operational excellence to Sanovas. As importantly, they are passionate about the urgency of our mission to increase survival and improve the quality of life for the millions of patients suffering from lung cancer and pulmonary disease."

With over 30 years experience in management, clinical sales and marketing in the medical device industry, Mike Humason will lead Sanovas' clinical operations. Humason has faithfully served to advance innovation in surgical science through physician education and patient care initiatives on behalf of such esteemed companies as ERBE USA, Midmark Surgical, Datel Systems and Karl Storz. Most recently, he led the start-up efforts for Given Imaging, Inc., where he was instrumental in managing pre-market clinical trials and the post-approval sales efforts of the company's revolutionary 'Pill Cam', Capsule endoscopy system for diagnostic imaging of the GI Tract.

Carlos Gonzalez joins Sanovas as an industry veteran with more than 35 years of experience serving vital roles in engineering, operations, regulatory affairs, quality assurance and corporate compliance. Mr. Gonzalez' career spanned operational roles in biologics at Alpha Therapeutics and Pfizer as well as engineering and quality roles in high volume medical device production at Baxter.

Prior to joining Sanovas, Mr. Gonzalez served as vice president of regulatory affairs, quality assurance and corporate compliance for Stryker Endoscopy, a division of Stryker Corp. At Stryker, Carlos was responsible for nearly 100 successful FDA 510(k) submissions and dozens of foreign product submissions over 15 years. His leadership contributed to the growth of three newly acquired business units; taking the company from 55 to over 1000 employees and from $60 million to over $550 million in revenues.

As chief financial officer, Robert E. Farrell's credentials encompass all aspects and responsibilities of being the chief financial officer of a public company, including all financial, accounting, SEC, Sarbanes-Oxley, public relations and investor activities. He is a highly seasoned corporate executive and lawyer with over 35 years' experience serving as general counsel, president and CEO and as executive vice president and CFO. Mr. Farrell possesses extensive financing experience with private placements, initial public offerings, mergers, acquisitions, licensing and strategic corporate partnerships on behalf of Brae Corporation, GenStar, Fresenius and Titan Pharmaceuticals.

Prior to joining Sanovas, Bob served as the president, CEO and CFO of Titan Pharmaceuticals, where he was responsible for all financial, accounting, SEC and investor activities at the company. He structured numerous licenses, sales and acquisitions of the company's assets in driving operational efficiencies that structured and re-purposed the company's focus. Prior to that, he served as the Corporate Group vice president and CFO at Fresenius USA.  While at Fresenius USA, Farrell oversaw the company's initial public offering, nine merger and acquisition transactions and all financial, accounting, insurance, SEC, legal and investor relations activities.  Serving as president of GenStar's, TXL Securities division, he managed dozens of corporate financing transactions in growing the corporate finance business of the company. Mr. Farrell earned his Bachelor of Arts in government from University of Notre Dame and his Juris Doctorate from University of California, Hastings College of Law.

Sanovas' Vas Zeppelin™ Smart Catheter technology portfolio is designed to access, image, measure, and diagnose anatomy in small airways and vessels residing at, or below, three millimeters in diameter. Featuring the world's smallest surgical camera, the Vas Zeppelin™ allows the removal of tumors and other obstructions and enables the local delivery of drug and immune therapies to patients suffering from lung cancer and related pulmonary and vascular diseases.  

About Sanovas

Sanovas Inc., based in Sausalito, Calif., is a medical technology company focused on developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies for unmet clinical needs. Sanovas' microsurgical technology platform is designed to give surgeons the ability to access and visualize previously inaccessible areas of the body; enabling them to diagnose, treat and deliver drug and immune therapies to small diameter anatomy in entirely new ways. Privately held, Sanovas was founded by the pioneers in minimally invasive surgery. The company has more than 45 multi-national patents pending.

Media Contacts:                                          

Racepoint Group
For Sanovas
Susan Thomas, 619-540-9195


'/>"/>
SOURCE Sanovas Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sanovas Forms Scientific Advisory Board to Support Development of Lung Cancer Technology
2. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
3. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
4. Survey Shows eContent Critical to Corporate Strategies
5. Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series
6. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
7. Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com
8. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
9. Accuray Incorporated to Speak at Jefferies Global Healthcare Conference
10. InfuSystem Holdings Modifies Bylaws to Align with Corporate Governance Best Practices
11. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... India , May 25, 2016 ... Animation Market by Type (3D, 2D, 4D), by Therapeutic ... Education), by End User (Medical Device Manufacturers, Hospitals/ Clinics) ... studies the global Medical Animation Market for the forecast ... to reach USD 301.3 Million by 2021 from USD ...
(Date:5/25/2016)... 2016  According to Kalorama Information, the world ... 2015.  Though these are challenging times in the ... success for companies that remain optimistic and seek ... growth prospects medical device companies spend a higher ... (R&D) than do companies in other industries.  Also, ...
(Date:5/25/2016)... , May 25, 2016 Digital ... issuance to it by the US Patent and ... company,s technology includes proprietary processes for electronic opt-­in ... health and wellness programs, HIPAA compliance and otherwise. ... "Our technology allows ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of ... today announced the organization has earned its ISO 13485 certification, indicating the company’s ... with all rules and policies associated with ISO quality standard 13485. , ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Lung Institute has partnered ... cessation class starting June 6 at their clinic in downtown Tampa. The class is ... the Lung Institute has created a free downloadable 4 Week Smoking Cessation Guide ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... offering campers a multitude of activities from daily practices, arts & crafts, discussions, ... Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, ...
(Date:5/26/2016)... ... May 26, 2016 , ... The MIAMI Institute for Age ... speaker Dr. Adonis Maiquez MD, ABAARM. Dr. Adonis , Wellness Physician of the ... a member of the Institute for Functional Medicine. , He also heads up FITTLab, ...
(Date:5/26/2016)... ... 2016 , ... Power Systems, a leading developer and supplier ... Course in Stoughton, Massachusetts. The course was led by Power Systems’ Education Coordinator, ... interactive course to qualify participants as certified PowerWave trainers. , PowerWave is ...
Breaking Medicine News(10 mins):